Search alternatives:
significantly promoted » significantly related (Expand Search), significantly reduced (Expand Search), significantly improved (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
promoted decrease » promote disease (Expand Search), reported decrease (Expand Search)
Showing 2,041 - 2,060 results of 21,342 for search '(( significant decrease decrease ) OR ( significantly promoted decrease ))*', query time: 0.37s Refine Results
  1. 2041
    The trends in the expression of inflammation-related genes in liver tissue.

    The trends in the expression of inflammation-related genes in liver tissue. by Xueqin lu (22250795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 2042
    The Fibrosis scoring by Sirius Red staining and SHG/TPEF.

    The Fibrosis scoring by Sirius Red staining and SHG/TPEF. by Xueqin lu (22250795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 2043
    Effects of Kylo-0603 on body weight, organ weight, and body fat content.

    Effects of Kylo-0603 on body weight, organ weight, and body fat content. by Xueqin lu (22250795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 2044
    The trends in the expression of fibrosis-related genes in liver tissue.

    The trends in the expression of fibrosis-related genes in liver tissue. by Xueqin lu (22250795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 2045
    Effects of Kylo-0603 on the expression of related genes of the MASH mouse models.

    Effects of Kylo-0603 on the expression of related genes of the MASH mouse models. by Xueqin lu (22250795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 2046
    Plasma cholesterol and LDL-C levels.

    Plasma cholesterol and LDL-C levels. by Xueqin lu (22250795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 2047
    <sup>13</sup>C NMR spectra for Kylo-0603.

    <sup>13</sup>C NMR spectra for Kylo-0603. by Xueqin lu (22250795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 2048
    General procedure for the synthesis of A and A-c1.

    General procedure for the synthesis of A and A-c1. by Xueqin lu (22250795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 2049
    Hematoxylin and eosin (H&E) staining, Sirius Red staining, and Oil Red staining of liver tissues from mice in each group after 8 weeks of treatment with either vehicle or Kylo-0603 (0.1–10 mg/kg/day, as indicated).

    Hematoxylin and eosin (H&E) staining, Sirius Red staining, and Oil Red staining of liver tissues from mice in each group after 8 weeks of treatment with either vehicle or Kylo-0603... by Xueqin lu (22250795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 2050
    DIO Mice Liver Staining.

    DIO Mice Liver Staining. by Xueqin lu (22250795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 2051
    Trends of peroxisome-related gene expression in liver tissue.

    Trends of peroxisome-related gene expression in liver tissue. by Xueqin lu (22250795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 2052
    NAS (NAFLD Activity Score) of liver tissue of mice in each group after 8 weeks of treatment with either vehicle (V) or Kylo-0603 (0.1-10 mg/kg/day).

    NAS (NAFLD Activity Score) of liver tissue of mice in each group after 8 weeks of treatment with either vehicle (V) or Kylo-0603 (0.1-10 mg/kg/day). by Xueqin lu (22250795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 2053
    The body weight and cholesterol levels of the mice were recorded before the administration of the drug.

    The body weight and cholesterol levels of the mice were recorded before the administration of the drug. by Xueqin lu (22250795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 2054
    Effect of Kylo-0603 drug on the reversal of steatosis and inhibition of fibrotic process in liver tissues of the MASH mouse models (F2 ~ 3), analyzed by SHG/TPEF microscopy combined with digital image analysis technique.

    Effect of Kylo-0603 drug on the reversal of steatosis and inhibition of fibrotic process in liver tissues of the MASH mouse models (F2 ~ 3), analyzed by SHG/TPEF microscopy combine... by Xueqin lu (22250795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 2055
    The structures of T3 and Kylo-0603.

    The structures of T3 and Kylo-0603. by Xueqin lu (22250795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 2056
    Synthesis process of Kylo-0603.

    Synthesis process of Kylo-0603. by Xueqin lu (22250795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 2057
    ESI-HRMS spectra for Kylo-0603.

    ESI-HRMS spectra for Kylo-0603. by Xueqin lu (22250795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 2058
    General procedure for the synthesis of Kylo-0603.

    General procedure for the synthesis of Kylo-0603. by Xueqin lu (22250795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 2059
    Alterations in CBC parameters in albino rats of both genders after 60 days of administration of dimethoate presented in Mean ± S.E.M. and their significance level.

    Alterations in CBC parameters in albino rats of both genders after 60 days of administration of dimethoate presented in Mean ± S.E.M. and their significance level. by Nida Saleem (17194610)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 2060
    Alterations in CBC parameters in albino rats of both genders after 30 days of administration of dimethoate presented in Mean ± S.E.M. and their significance level.

    Alterations in CBC parameters in albino rats of both genders after 30 days of administration of dimethoate presented in Mean ± S.E.M. and their significance level. by Nida Saleem (17194610)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: